|
2026-02-17 |
2026-02-12 |
B
Purchase
|
Head of Pharm Ops and Tech
Officer
|
97,991
-48.6%
445.67
US$4,496,579
|
97,991
-48.6%
|
445.67
|
US$4,496,579
|
|
|
2026-02-10 |
2026-02-09 |
S
Sale
|
Head of Development
Officer
|
27,486
-45.2%
53.15
US$1,858,513
|
27,486
-45.2%
|
53.15
|
US$1,858,513
|
|
|
2026-02-09 |
2026-02-09 |
PrS
Proposed sale
|
Officer
Officer
|
30,414
182.82
US$3,951,409
|
30,414
|
182.82
|
US$3,951,409
|
|
|
2026-02-03 |
2026-02-02 |
S
Sale
|
Head of Development
Officer
|
748
-10.7%
179.30
US$134,116
|
748
-10.7%
|
179.30
|
US$134,116
|
|
|
2026-02-03 |
2026-02-02 |
S
Sale
|
Head of Development
Officer
|
748
-10.7%
179.30
US$134,116
|
748
-10.7%
|
179.30
|
US$134,116
|
|
|
2026-02-02 |
2026-02-02 |
PrS
Proposed sale
|
Officer
Officer
|
748
179.30
US$134,116
|
748
|
179.30
|
US$134,116
|
|
|
2025-09-02 |
2025-09-02 |
PrS
Proposed sale
|
Officer
Officer
|
517
133.55
US$69,045
|
517
|
133.55
|
US$69,045
|
|
|
2025-09-02 |
2025-09-02 |
S
Sale
|
Head of Development
Officer
|
517
-8.2%
133.55
US$69,045
|
517
-8.2%
|
133.55
|
US$69,045
|
|
|
2025-07-16 |
2025-07-08 |
S
Sale
|
Head of Global Product Strat.
Officer
|
2,223
-26.0%
135.00
US$300,105
|
2,223
-26.0%
|
135.00
|
US$300,105
|
|
|
2025-07-08 |
2025-07-08 |
PrS
Proposed sale
|
Officer
Officer
|
2,223
135.00
US$300,105
|
2,223
|
135.00
|
US$300,105
|
|
|
2025-05-20 |
2025-05-19 |
PlS
Planned sale
|
Head of Development
Officer
|
3,806
-41.2%
126.25
US$480,508
|
3,806
-41.2%
|
126.25
|
US$480,508
|
|
|
2025-05-19 |
2025-05-19 |
PrS
Proposed sale
|
Officer
Officer
|
3,806
126.25
US$480,508
|
3,806
|
126.25
|
US$480,508
|
|
|
2025-05-05 |
2025-05-02 |
B
Purchase
|
Non-Executive Director
|
1,235
+4.6%
122.72
US$151,559
|
1,235
+4.6%
|
122.72
|
US$151,559
|
|
|
2025-03-10 |
2025-03-07 |
S
Sale
|
Non-Executive Director
|
8,760
-43.6%
150.02
US$1,314,142
|
8,760
-43.6%
|
150.02
|
US$1,314,142
|
|
|
2025-03-07 |
2025-03-07 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
8,760
147.37
US$1,290,961
|
8,760
|
147.37
|
US$1,290,961
|
|
|
2024-12-09 |
2024-12-09 |
PrS
Proposed sale
|
Officer
Officer
|
110
157.21
US$17,293
|
110
|
157.21
|
US$17,293
|
|
|
2024-12-09 |
2024-12-09 |
S
Sale
|
Head of Development
Officer
|
110
-2.0%
157.21
US$17,293
|
110
-2.0%
|
157.21
|
US$17,293
|
|
|
2024-09-05 |
2024-09-03 |
S
Sale
|
Head of Development
Officer
|
431
-7.5%
204.22
US$88,019
|
431
-7.5%
|
204.22
|
US$88,019
|
|
|
2024-09-03 |
2024-09-03 |
PrS
Proposed sale
|
Officer
Officer
|
431
204.22
US$88,019
|
431
|
204.22
|
US$88,019
|
|
|
2024-04-03 |
2024-04-02 |
PlS
Planned sale
|
Head of Development
Officer
|
93
-1.9%
213.09
US$19,817
|
93
-1.9%
|
213.09
|
US$19,817
|
|
|
2024-04-02 |
2024-04-02 |
PrS
Proposed sale
|
Officer
Officer
|
93
213.09
US$19,817
|
93
|
213.09
|
US$19,817
|
|
|
2024-02-26 |
2024-02-22 |
S
Sale
|
Head of Development
Officer
|
262
-5.1%
221.23
US$57,962
|
262
-5.1%
|
221.23
|
US$57,962
|
|
|
2024-02-22 |
2024-02-22 |
PrS
Proposed sale
|
Officer
Officer
|
262
221.23
US$57,962
|
262
|
221.23
|
US$57,962
|
|
|
2024-02-21 |
2024-02-21 |
PrS
Proposed sale
|
Officer
Officer
|
108
221.49
US$23,921
|
108
|
221.49
|
US$23,921
|
|
|
2024-02-21 |
2024-02-16 |
S
Sale
|
Head of Development
Officer
|
108
-2.1%
221.49
US$23,921
|
108
-2.1%
|
221.49
|
US$23,921
|
|
|
2024-02-20 |
2024-02-15 |
B
Purchase
|
Non-Executive Director
|
455
+2.3%
222.54
US$101,256
|
455
+2.3%
|
222.54
|
US$101,256
|
|
|
2024-02-13 |
2024-02-12 |
S
Sale
|
Head of Development
Officer
|
419
-8.5%
239.45
US$100,330
|
419
-8.5%
|
239.45
|
US$100,330
|
|
|
2024-02-12 |
2024-02-12 |
PrS
Proposed sale
|
Officer
Officer
|
419
239.45
US$100,330
|
419
|
239.45
|
US$100,330
|
|
|
2024-02-05 |
2024-02-02 |
S
Sale
|
Head of Development
Officer
|
634
-13.4%
245.93
US$155,920
|
634
-13.4%
|
245.93
|
US$155,920
|
|
|
2024-02-02 |
2024-02-02 |
PrS
Proposed sale
|
Officer
Officer
|
634
245.93
US$155,920
|
634
|
245.93
|
US$155,920
|
|
|
2023-12-12 |
2023-12-11 |
S
Sale
|
Head of Development
Officer
|
110
-3.1%
248.00
US$27,280
|
110
-3.1%
|
248.00
|
US$27,280
|
|
|
2023-12-11 |
2023-12-11 |
PrS
Proposed sale
|
Officer
Officer
|
110
248.00
US$27,280
|
110
|
248.00
|
US$27,280
|
|
|
2023-09-06 |
2023-09-05 |
S
Sale
|
Head of Development
Officer
|
431
-11.4%
269.43
US$116,124
|
431
-11.4%
|
269.43
|
US$116,124
|
|
|
2023-09-05 |
2023-09-05 |
PrS
Proposed sale
|
Officer
Officer
|
431
269.43
US$116,124
|
431
|
269.43
|
US$116,124
|
|
|
2023-07-05 |
2023-07-03 |
S
Sale
|
Head of Development
Officer
|
81
-2.7%
282.87
US$22,912
|
81
-2.7%
|
282.87
|
US$22,912
|
|
|
2023-07-03 |
2023-07-03 |
PrS
Proposed sale
|
Officer
Officer
|
81
282.87
US$22,912
|
81
|
282.87
|
US$22,912
|
|
|
2023-05-02 |
2023-04-28 |
PlS
Planned sale
|
EVP, Human Resources
Officer
|
2,681
-24.0%
300.00
US$804,300
|
2,681
-24.0%
|
300.00
|
US$804,300
|
|
|
2023-04-28 |
2023-04-28 |
PrS
Proposed sale
|
Officer
Officer
|
2,681
300.00
US$804,300
|
2,681
|
300.00
|
US$804,300
|
|
|
2023-04-06 |
2023-04-04 |
PlS
Planned sale
|
Head of Development
Officer
|
91
-3.1%
277.11
US$25,217
|
91
-3.1%
|
277.11
|
US$25,217
|
|
|
2023-04-04 |
2023-04-04 |
PrS
Proposed sale
|
Officer
Officer
|
91
277.11
US$25,217
|
91
|
277.11
|
US$25,217
|
|
|
2023-03-30 |
2023-03-28 |
PlS
Planned sale
|
Head of Development
Officer
|
568
-16.7%
270.06
US$153,394
|
568
-16.7%
|
270.06
|
US$153,394
|
|
|
2023-03-28 |
2023-03-28 |
PrS
Proposed sale
|
Officer
Officer
|
568
270.06
US$153,394
|
568
|
270.06
|
US$153,394
|
|
|
2022-12-12 |
2022-11-14 |
PlS
Planned sale
|
EVP, Human Resources
Officer
|
5,610
-49.6%
300.11
US$1,683,617
|
5,610
-49.6%
|
300.11
|
US$1,683,617
|
|
|
2022-10-28 |
2022-10-27 |
PlS
Planned sale
|
EVP Chief Legal Off & Corp Sec
Officer
|
5,532
-12.3%
280.70
US$1,552,832
|
5,532
-12.3%
|
280.70
|
US$1,552,832
|
|
|
2021-06-09 |
2021-06-07 |
PlS
Planned sale
|
Head of Research & Development
Officer
|
7,672
-43.0%
440.00
US$3,375,680
|
7,672
-43.0%
|
440.00
|
US$3,375,680
|
|
|
2021-06-07 |
2021-06-04 |
PlS
Planned sale
|
Non-Executive Director
|
360
-4.6%
274.17
US$98,701
|
360
-4.6%
|
274.17
|
US$98,701
|
|
|
2021-02-10 |
2021-02-09 |
B
Purchase
|
Non-Executive Director
|
898
+43.9%
267.00
US$239,766
|
898
+43.9%
|
267.00
|
US$239,766
|
|
|
2020-12-01 |
2020-11-30 |
PP
Planned purchase
|
Chief Executive Officer
Executive Director
|
3,100
+9.8%
241.31
US$748,047
|
3,100
+9.8%
|
241.31
|
US$748,047
|
|
|
2020-11-06 |
2020-11-04 |
PlS
Planned sale
|
EVP, Research & Development
Officer
|
1,500
-10.3%
350.00
US$525,000
|
1,500
-10.3%
|
350.00
|
US$525,000
|
|
|
2020-03-12 |
2020-03-11 |
PlS
Planned sale
|
Non-Executive Director
|
270
-1.7%
295.29
US$79,728
|
270
-1.7%
|
295.29
|
US$79,728
|
|
|
2020-03-12 |
2020-03-11 |
PlS
Planned sale
|
Non-Executive Director
|
2,164
-13.1%
295.22
US$638,845
|
2,164
-13.1%
|
295.22
|
US$638,845
|
|
|
2019-12-03 |
2019-12-02 |
PlS
Planned sale
|
Posner Brian S
Non-Executive Director
|
1,055
-13.1%
292.35
US$308,429
|
1,055
-13.1%
|
292.35
|
US$308,429
|
|
|
2019-05-02 |
2019-05-02 |
B
Purchase
|
Non-Executive Director
|
38,000
+6.3%
231.24
US$8,787,120
|
38,000
+6.3%
|
231.24
|
US$8,787,120
|
|
|
2019-05-02 |
2019-05-01 |
PP
Planned purchase
|
Chief Executive Officer
Executive Director
|
4,351
+26.1%
231.48
US$1,007,169
|
4,351
+26.1%
|
231.48
|
US$1,007,169
|
|
|
2019-05-02 |
2019-05-01 |
B
Purchase
|
Non-Executive Director
|
30,000
+5.2%
229.46
US$6,883,800
|
30,000
+5.2%
|
229.46
|
US$6,883,800
|
|
|
2019-05-02 |
2019-04-30 |
B
Purchase
|
Non-Executive Director
|
50,342
+9.6%
229.25
US$11,540,904
|
50,342
+9.6%
|
229.25
|
US$11,540,904
|
|
|
2019-03-19 |
2019-03-18 |
PlS
Planned sale
|
|
6,114
-24.8%
328.55
US$2,008,755
|
6,114
-24.8%
|
328.55
|
US$2,008,755
|
|
|
2019-02-01 |
2019-02-01 |
B
Purchase
|
Non-Executive Director
|
7,000
+1.4%
328.45
US$2,299,163
|
7,000
+1.4%
|
328.45
|
US$2,299,163
|
|
|
2019-02-01 |
2019-01-31 |
B
Purchase
|
Non-Executive Director
|
25,800
+5.2%
330.52
US$8,527,393
|
25,800
+5.2%
|
330.52
|
US$8,527,393
|
|
|
2019-02-01 |
2019-01-30 |
B
Purchase
|
Non-Executive Director
|
30,000
+6.5%
324.86
US$9,745,851
|
30,000
+6.5%
|
324.86
|
US$9,745,851
|
|
|
2018-09-27 |
2018-09-26 |
PlS
Planned sale
|
Ehlers Michael D
EVP, Research and Development
Officer
|
1,000
-18.9%
350.00
US$350,000
|
1,000
-18.9%
|
350.00
|
US$350,000
|
|
|
2018-04-27 |
2018-04-25 |
B
Purchase
|
DENNER ALEXANDER J
Non-Executive Director
|
48,000
+11.6%
269.91
US$12,955,680
|
48,000
+11.6%
|
269.91
|
US$12,955,680
|
|
|
2018-02-28 |
2018-02-27 |
PlS
Planned sale
|
Sandrock Alfred
EVP, Chief Medical Officer
Officer
|
259
-3.8%
290.83
US$75,325
|
259
-3.8%
|
290.83
|
US$75,325
|
|
|
2018-02-27 |
2018-02-23 |
PlS
Planned sale
|
Sandrock Alfred
EVP, Chief Medical Officer
Officer
|
908
-12.2%
293.44
US$266,444
|
908
-12.2%
|
293.44
|
US$266,444
|
|
|
2018-02-21 |
2018-02-20 |
PlS
Planned sale
|
Sandrock Alfred
EVP, Chief Medical Officer
Officer
|
743
-10.2%
292.00
US$216,956
|
743
-10.2%
|
292.00
|
US$216,956
|
|
|
2018-02-20 |
2018-02-15 |
PlS
Planned sale
|
Sandrock Alfred
EVP, Chief Medical Officer
Officer
|
1,294
-15.1%
298.85
US$386,712
|
1,294
-15.1%
|
298.85
|
US$386,712
|
|
|
2018-01-10 |
2018-01-09 |
PlS
Planned sale
|
PANGIA ROBERT W
Non-Executive Director
|
5,832
-24.8%
329.65
US$1,922,519
|
5,832
-24.8%
|
329.65
|
US$1,922,519
|
|
|
2018-01-02 |
2017-12-29 |
PP
Planned purchase
|
Vounatsos Michel
Chief Executive Officer
Executive Director
|
780
+19.0%
320.55
US$250,029
|
780
+19.0%
|
320.55
|
US$250,029
|
|
|
2017-11-30 |
2017-11-29 |
B
Purchase
|
DENNER ALEXANDER J
|
10,000
+2.5%
319.84
US$3,198,400
|
10,000
+2.5%
|
319.84
|
US$3,198,400
|
|
|
2017-11-30 |
2017-11-28 |
B
Purchase
|
DENNER ALEXANDER J
|
20,000
+5.2%
316.12
US$6,322,400
|
20,000
+5.2%
|
316.12
|
US$6,322,400
|
|
|
2017-07-26 |
2017-07-25 |
PlS
Planned sale
|
ALEXANDER SUSAN H
EVP Chief Legal Corp Svc & Sec
Officer
|
4,974
-18.3%
290.01
US$1,442,510
|
4,974
-18.3%
|
290.01
|
US$1,442,510
|
|
|
2017-07-20 |
2017-07-19 |
PlS
Planned sale
|
ALEXANDER SUSAN H
EVP Chief Legal Corp Svc & Sec
Officer
|
7,758
-22.2%
285.00
US$2,211,030
|
7,758
-22.2%
|
285.00
|
US$2,211,030
|
|
|
2017-06-12 |
2017-06-09 |
PlS
Planned sale
|
Posner Brian S
|
1,084
-14.6%
256.31
US$277,840
|
1,084
-14.6%
|
256.31
|
US$277,840
|
|
|
2017-05-02 |
2017-05-01 |
PP
Planned purchase
|
Vounatsos Michel
Chief Executive Officer
Executive Director
|
1,402
+91.9%
271.35
US$380,433
|
1,402
+91.9%
|
271.35
|
US$380,433
|
|
|
2017-05-01 |
2017-04-27 |
B
Purchase
|
DENNER ALEXANDER J
Non-Executive Director
|
58,858
+18.1%
278.48
US$16,390,776
|
58,858
+18.1%
|
278.48
|
US$16,390,776
|
|